1. Home
  2. CMCO vs VIR Comparison

CMCO vs VIR Comparison

Compare CMCO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$17.60

Market Cap

492.7M

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.54

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
VIR
Founded
1875
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.7M
773.5M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CMCO
VIR
Price
$17.60
$6.54
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$35.00
$25.73
AVG Volume (30 Days)
225.5K
1.8M
Earning Date
10-30-2025
11-05-2025
Dividend Yield
1.59%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$977,994,000.00
$16,860,000.00
Revenue This Year
$5.60
N/A
Revenue Next Year
$4.23
$48.05
P/E Ratio
$134.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.78
$4.16
52 Week High
$39.26
$14.45

Technical Indicators

Market Signals
Indicator
CMCO
VIR
Relative Strength Index (RSI) 62.98 56.09
Support Level $16.62 $6.49
Resistance Level $18.15 $6.97
Average True Range (ATR) 0.53 0.43
MACD 0.11 0.02
Stochastic Oscillator 74.44 66.77

Price Performance

Historical Comparison
CMCO
VIR

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: